Clinical Trial Update: A Non-inferiority Study to Evaluate Efficacy, Safety and Tolerability of NEUMOTEROL® 400 and SYMBICORT® Forte in Adults With Asthma [Phase 4]

View source ↗

Summary

Phase 4 non-inferiority trial evaluating NEUMOTEROL 400 versus SYMBICORT Forte in adults with asthma; study completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• NEUMOTEROL 400
• SYMBICORT Forte

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2017-08-18